Hypoxic and redox inhibition of the human cardiac L-type Ca2+ channel.
Fearon
I M
IM
Institute for Cardiovascular Research, University of Leeds, U.K.
Palmer
A C
AC
Balmforth
A J
AJ
Ball
S G
SG
Varadi
G
G
Peers
C
C
D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D020746:Calcium Channels, L-Type / Q000235:genetics / Q000378:metabolism*; D015687:Cell Hypoxia / Q000502:physiology; D002460:Cell Line; D004229:Dithiothreitol / Q000494:pharmacology; D005020:Ethyl Methanesulfonate / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D008698:Mesylates / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D014162:Transfection
D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D008698:Mesylates; D011994:Recombinant Proteins; C093171:methanethiosulfonate ethylammonium; C109153:(2-sulfonatoethyl)methanethiosulfonate; D002731:4-Chloromercuribenzenesulfonate; D005020:Ethyl Methanesulfonate; D004229:Dithiothreitol